U.S. nod for Chennai pharma major's antibiotic
Facebook Twitter google+ RSS Feed

U.S. nod for Chennai pharma major's antibiotic

Tuesday, 25 February 2003, 08:00 Hrs
Printer Print Email Email
CHENNAI: An antibiotic manufactured by a Chennai-based company has been okayed for entry into the U.S.

Orchid Chemicals & Pharmaceuticals Ltd. has received a formal approval from the U.S. Federal Drug Authority (USFDA) to make Cephalexine.

The product has also been granted the certificate of suitability (CoS) by the European Directorate for Quality of Medicines (EDQM). The company has been granted CoS for Ceftriaxone sodium.

"We are extremely happy about these developments. Both these milestones will definitely enable a stronger entry into the U.S. and European markets," K. Raghavendra Rao, managing director of Orchid Chemicals, said here.

Orchid is India's largest cephalosporin-based drug manufacturer.




Source: IANS
Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset